Incidence of infection other than tuberculosis in patients with autoimmune rheumatic diseases treated with bDMARDs: a real-time clinical experience from India-Reference-Cited by-同舟云学术

Incidence of infection other than tuberculosis in patients with autoimmune rheumatic diseases treated with bDMARDs: a real-time clinical experience from India

Published:2019-01-25 Issue:3 Volume:39 Page:497-507
ISSN:0172-8172
Container-title:Rheumatology International
language:en
Short-container-title:Rheumatol Int

Author:

Chandrashekara S.^ORCID,Shobha Vineeta,Rao Vijay,Desai Anu^ORCID,Jois Ramesh,Dharmanand B. G.,Kumar Sharath,Kumar Pradeep,Dharmapalaiah Chethana,Mahendranath Kurugodu Mathada,Prasad Shiva,Daware Manisha Ashwin,Singh Yogesh,Karjigi Uma,Nagaraj S.,Anupama K. R.

Funder

Karnataka Rheumatology Association

Publisher

Springer Science and Business Media LLC

Subject

Immunology,Immunology and Allergy,Rheumatology

Link

http://link.springer.com/article/10.1007/s00296-019-04245-4/fulltext.html

Reference25 articles.

1. Yamanaka H, Goto K, Suzuki M (2012) Bacterial infection in the limbs of patients with rheumatoid arthritis during biological agent therapy. Open J Rheumatol Autoimmune Dis 2:47–52

2. Hofmann K, Clauder A-K, Manz RA (2018) Targeting B cells and plasma cells in autoimmune diseases. Front Immunol 9:835

3. Boyman O, Comte D, Spertini F (2014) Adverse reactions to biologic agents and their medical management. Nat Rev Rheumatol 10:612–627